glp-1 shortage Ro launches supply tracker to help patients navigate shortages The GLP-1 drug shortage is
Description
Lancet 400(10366):18691881
The information in this blog is subject to change without notice
Compound selection should be driven by demonstrated brain exposure rather than commercial prominence
In clinical trials, GLP-1s enhanced smoking cessation outcomes when paired with nicotine patches
One company is Zealand Pharma, which presented mid-stage data from a drug called petrelintide that it's developing with Roche
In a study using the GLP-1R agonist liraglutide, its ability to reverse cognitive deficits in an AD model and its potential neuroprotective mechanisms were identified
